Alcon AG
NYSE:ALC

Watchlist Manager
Alcon AG Logo
Alcon AG
NYSE:ALC
Watchlist
Price: 84.76 USD 0.69% Market Closed
Market Cap: 42.1B USD
Have any thoughts about
Alcon AG?
Write Note

Alcon AG
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alcon AG
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Alcon AG
SIX:ALC
Revenue
$9.5B
CAGR 3-Years
11%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
Revenue
CHf238.8m
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Medartis Holding AG
SIX:MED
Revenue
CHf220.3m
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Revenue
CHf617.1m
CAGR 3-Years
13%
CAGR 5-Years
10%
CAGR 10-Years
8%
IVF Hartmann Holding AG
SIX:VBSN
Revenue
CHf152.9m
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
2%
No Stocks Found

Alcon AG
Revenue Breakdown

Breakdown by Geography
Alcon AG

Total Revenue: 9.5B USD
100%
Countries Other Than United States: 5.1B USD
53.5%
United States: 4.3B USD
45.6%
Other Countries: 3.9B USD
41.1%
Japan: 583m USD
6.2%
China: 526m USD
5.6%
Switzerland: 64m USD
0.7%
Show More
Show Less

Breakdown by Segments
Alcon AG

Not Available

Alcon AG
Glance View

Market Cap
41.9B USD
Industry
Health Care

Alcon AG, headquartered in Geneva, Switzerland, emerges as a global leader in eye care, having spun off from Novartis in 2019 to operate independently. The company traces its roots back to a small pharmacy established in Fort Worth, Texas, in 1945, gradually expanding under the strategic vision of its founders. Today, Alcon stands at the intersection of innovation and necessity, catering to a world increasingly aware of eye health. The firm specializes in two main sectors: Surgical and Vision Care. In the Surgical division, Alcon offers advanced technologies and devices for ophthalmic surgery, encompassing cataract, retinal, and refractive procedures. Through these innovations, Alcon not only enhances patient outcomes but also streamlines operations for eye care professionals, carving out a significant market share in surgical solutions. Meanwhile, the Vision Care segment thrives by addressing the burgeoning demand for contact lenses and ocular health products. Alcon’s portfolio features daily disposable and reusable lenses, supported by innovative technologies that prioritize comfort and clarity of vision. Additionally, the company provides comprehensive eye care products, including lens care solutions, which enhance user satisfaction and ensure sustained demand. Alcon’s revenue model hinges on its ability to deliver cutting-edge products that meet the evolving needs of consumers and professionals alike. Through strategic investments in research and development and a strong distribution network, Alcon perpetually reinforces its market presence, securing its position as a formidable player in the eye care industry.

ALC Intrinsic Value
81.43 USD
Overvaluation 4%
Intrinsic Value
Price

See Also

What is Alcon AG's Revenue?
Revenue
9.5B USD

Based on the financial report for Dec 31, 2023, Alcon AG's Revenue amounts to 9.5B USD.

What is Alcon AG's Revenue growth rate?
Revenue CAGR 5Y
6%

Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Alcon AG have been 11% over the past three years , 6% over the past five years .

Back to Top